This is a preview to the Era of Wisdom documentary Toddlers on Adderall: History of Big Pharma and the Major Players, to be released December 28, 2016.
The film is written and directed by Cassius Kamarampi, narrated by Josh Mur and it’s music is by Cassius Kamarampi.
Transcript of the video
In our society, we often correlate legality with safety. We use household products, spray pesticides, and religiously consume drugs such as ritalin, adderall, oxycontin, and prozac.
We consume all of this, but how many know who made the drugs, and where the corporations came from? Who produces the chemicals we trust on a daily basis?
13 corporations tend to be a blind spot in our understanding of history.
Tens of thousands of american toddlers are being prescribed amphetamine – a result of this blind spot. Neos Therapeutics is responsible for candy flavored children’s amphetamine, sold as adzenys. Shire created adderall.
An understanding of Big Pharma is conducive to a big picture understanding of the world and power itself: it is an essential puzzle piece in understanding disease, hegemony, and health.
For instance, we have Purdue. Purdue Pharma was created in 1892 New York. They are arguably responsible for the epidemic of opioid addiction in the United States, producing hydrocodone, oxycontin, fentanyl, codeine, hydromorphone, and oxycodone.
Novartis is the world’s largest pharmaceutical corporation by revenue, headquartered in Basel, Switzerland, a 1996 merger between Ciba-Geigy and Sandoz.
Novartis is responsible for many drugs, from ritalin to LSD. Novartis has a long criminal record. They are known for animal cruelty, from drilling the heads of cats open, to experimenting on primates.
Sandoz polluted the Rhine River in the 1986 Sandoz Chemical Spill.
Novartis owned Syngenta, one of the world’s largest producers of pesticides and GMO seeds.
Recently Syngenta was sold to the Chinese government. State-owned Chem-China is now one of the world’s largest producers of pesticides and GM seeds.
Novartis coerces entire countries into banning cheaper, generic versions of their cancer drugs: namely Colombia. Leaked letters revealed Novartis’ control over the Senate Finance Committee, as Colombia was warned their 450$ million dollars in “Peace Colombia” money would be in jeopardy if they did not crack down on generic versions of the cancer drug gleevec.